Trials / Completed
CompletedNCT05988970
Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Institut Claudius Regaud · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective pilot study designed to demonstrate the impact of circadian rhythm on the spread of Circulating Tumor Cells (CTCs) in patients with Non- Small Cell Lung Cancer - NSCLC. 27 patients will be included in the study and will be followed for 12 months. For each included patient, blood samples will be collected before the anticancer treatment initiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood samples will be collected at two times before the treatment initiation: | * at 4:00 a.m. * at 10:00 a.m. Patients will then be followed for data collection for a period of 12 months after inclusion or until disease progression (if applicable). |
Timeline
- Start date
- 2024-01-29
- Primary completion
- 2026-01-21
- Completion
- 2026-01-21
- First posted
- 2023-08-14
- Last updated
- 2026-01-27
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05988970. Inclusion in this directory is not an endorsement.